Arkolith/Insider Trading/LVTX/Form 4

Dhingra Kapil

DirectorLAVA Therapeutics NV (LVTX) · full profile →Form 4 · filed Nov 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 13, 2025Disposed to issuer(D)30K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 13, 2025Disposed to issuer(D)33K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001456849-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML